Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit*
- 1 April 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 37 (4), 1463-1469
- https://doi.org/10.1097/ccm.0b013e31819ced02
Abstract
To review studies addressing mortality, length of stay (LOS), and cost of resistant Gram-negative bacterial infections in the intensive care unit (ICU). A qualitative review of published studies identified through PubMed search was performed. Study exclusion criteria were population Data Extraction and Synthesis: Twenty-one original studies and a meta-analysis, which included three of the original studies, were identified. Infections caused by mixed resistant Gram-negative bacteria, extended-spectrum β-lactamase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa, and Acinetobacter species were generally associated with increased mortality and LOS, especially in univariate analyses. Economic analyses performed in eight studies indicated that these resistant Gram-negative infections were also associated with increased patient charges or hospital costs. Associations sometimes disappeared in multivariate analyses after adjusting for variables significant in univariate analyses. The collective findings of the studies in this review suggested that Gram-negative bacterial resistance increases the burden in the ICU as measured by mortality, LOS, and charges. More prospective studies are needed to explore methods for combating Gram-negative resistance, including prevention, education, and better antimicrobial therapy. For example, well-designed research is needed to determine the cost-effectiveness of appropriate empiric therapy with broad-spectrum agents active against resistant Gram-negative bacteria followed by de-escalation.Keywords
This publication has 32 references indexed in Scilit:
- Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 2008
- Mortality and delay in effective therapy associated with extended-spectrum -lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2007
- The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumoniaDiagnostic Microbiology and Infectious Disease, 2007
- Cost of Gram-negative resistance*Critical Care Medicine, 2007
- Overview of Nosocomial Infections Caused by Gram-Negative BacilliClinical Infectious Diseases, 2005
- National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002Antimicrobial Agents and Chemotherapy, 2004
- International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial InfectionsAnnals of Internal Medicine, 2004
- Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patientsCritical Care Medicine, 2003
- Health and Economic Outcomes of the Emergence of Third-Generation Cephalosporin Resistance in Enterobacter SpeciesArchives of Internal Medicine, 2002
- Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on OutcomesClinical Infectious Diseases, 2001